Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study.
about
Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetesPrimary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studiesStatin Treatment and Mortality in Community-Dwelling Frail Older Patients with Diabetes Mellitus: A Retrospective Observational Study.Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility--Reykjavik Study (AGES-R).Carotid atherosclerosis and cardiovascular health metrics in old subjects from the AGES-Reykjavik study.Higher Plasma Phospholipid n-3 PUFAs, but Lower n-6 PUFAs, Are Associated with Lower Pulse Wave Velocity among Older Adults.Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study.Statin use and clinical outcomes in older men: a prospective population-based study.Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE studyPrevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study.Targeting hypertension in patients with cardiorenal metabolic syndrome.Changes in total cholesterol levels in Western societies are not related to statin, but rather dietary factors: the example of the Icelandic populationStatins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study
P2860
Q34057028-9CE389E3-AF97-4D21-9C58-CDA46717EEA0Q34491726-3E805DEC-BEAA-4FCA-A387-18824812DF4AQ34548552-E3BB0B32-FEE3-406C-899C-F642E41BF320Q35674469-648EFC76-508B-42F2-AFD0-951092020BE0Q35718004-1C2E0C92-51D9-4C12-989F-823814894EF0Q35988692-56AE122E-F8C0-46F7-8FF0-A1C478D39341Q36087812-38C9420C-5B90-457F-8430-09CADE4BD9B1Q36421107-8BA7DD53-8800-4C8F-8776-6C57FE78F9BAQ36730168-B9475D16-BDF7-4C79-8A18-30720024A1F0Q36984049-87590AFD-33C3-4B94-9F40-355735DA134FQ37516729-3830C367-3E71-4463-BE41-DC3AF79FC076Q38030808-A807D356-2018-4692-ABF8-BFEC206310D5Q57267020-57A5B96E-3C28-418C-A687-7FEAABB97D51Q58763818-AF349EF0-A4FD-4F7B-BCF1-17C032E651E3
P2860
Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effects of statin medication o ...... on-based AGES-Reykjavik Study.
@ast
Effects of statin medication o ...... on-based AGES-Reykjavik Study.
@en
type
label
Effects of statin medication o ...... on-based AGES-Reykjavik Study.
@ast
Effects of statin medication o ...... on-based AGES-Reykjavik Study.
@en
prefLabel
Effects of statin medication o ...... on-based AGES-Reykjavik Study.
@ast
Effects of statin medication o ...... on-based AGES-Reykjavik Study.
@en
P2093
P2860
P50
P1433
P1476
Effects of statin medication o ...... on-based AGES-Reykjavik Study.
@en
P2093
Bolli Thorsson
Elin Olafsdottir
Gunnar Sigurdsson
P2860
P304
P356
10.1136/BMJOPEN-2011-000132
P577
2011-01-01T00:00:00Z